Navigation Links
Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome
Date:11/20/2008

REINACH, Switzerland, November 20 /PRNewswire-FirstCall/ -- Arpida (SWX: ARPN) announced today that the Anti-infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 17 to 2 against the approval of intravenous iclaprim, an antibiotic currently in development for the treatment of patients with complicated skin and skin structure infections (cSSSIs), including those caused by methicillin-resistant Staphylococcus aureus (MRSA).

Arpida remains confident in the efficacy and safety of intravenous iclaprim and its potential in combating serious resistant infections. Iclaprim has been tested against both vancomycin and linezolid, and in combined Phase III studies that included nearly 1,000 patients with cSSSI, iclaprim has been shown to have high cure rates, exceeding 90 percent in the Per-Protocol population. Iclaprim has demonstrated potent bactericidal (killing) activity against MRSA and an extended range of resistant pathogens, with a well tolerated side-effect profile. Arpida is fully committed to iclaprim's development and will continue to work with the FDA to address any questions related to iclaprim in anticipation of the drug's Prescription Drug User Fee Act (PDUFA) goal date of January 16, 2009.

In addition to the FDA regulatory application, the European Medicines Agency (EMEA) accepted intravenous iclaprim for review August 2008. In September 2008, Arpida filed a New Drug Submission for intravenous iclaprim in Canada.

Arpida continues to study the potential of iclaprim, including investigation of an oral formulation. In early 2008, Arpida received FDA approval to conduct a Phase II iclaprim 'intravenous-to-oral' switch trial in patients with cSSSI. Patient enrolment was completed in September 2008 and results are expected in December 2008.

Additional studies are ongoing worldwide to investigate the use of intravenous iclaprim in hospital-acqui
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arpida Invited to Present Data on Iclaprim at Scientific Conference
2. Arpida Provides Further Comments on the Pivotal Phase III Trials
3. Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
4. Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
5. Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008
6. Pivotal Phase III Data Confirm the Efficacy and Safety of Arpidas Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
7. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
8. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
9. SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
10. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
11. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... LOS ANGELES , May 4, 2015 ... on FOX News online last week where he discussed ... device to be FDA-cleared. The FOX segment shows firsthand ... effective and affordable hair loss solution that will not ... light stimulates the mitochondria at the base of the ...
(Date:5/4/2015)... , May 4, 2015 Thirty-six million ... seek help. During May – National Hearing Month – ... could be missing out on the sounds of spring, ... trees. To ensure that you won,t be ... color our world, Oticon, Inc. offers practical advice: ...
(Date:5/4/2015)... , May 4, 2015 ... private equity firm, announced today that it ... company, BioPharm Communications. BioPharm specializes in the development ... for the pharmaceutical and biotechnology industries. ... to its shareholders half of their invested ...
Breaking Medicine Technology:FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2It's Better Hearing Month 2Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2
... Jan. 9 ESBATech AG, a leading developer of ... the Phase I/IIa clinical development of its anti-TNF ... double-blind, randomized, placebo-controlled Phase I/IIa clinical study is ... on pain with ESBA105 applied locally via intra-articular ...
... If you are taking prescription medicine,and forgot to ... people taking,prescription medicine don,t take it as prescribed. The ... priorities, or make a conscious,decision not to. Noncompliance has ... Surgeon General Everett Koop commented, "Drugs don,t,work in people ...
Cached Medicine Technology:ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 2ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 3ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 4Good Medicine: Smarter Smartphones for People With Chronic Disease 2
(Date:5/4/2015)... (PRWEB) May 04, 2015 Getting patients ... manage their health is critical to achieving the “triple ... reducing costs, but this will require a shift in ... also demands that health systems move beyond their traditional ... took part in the third live meeting of the ...
(Date:5/4/2015)... May 04, 2015 Johnson & Wales University ... engineering and science academic center on Wednesday, April 22. , ... for land made available by the re-alignment of Interstate-195. JWU’s ... of Friendship and Chestnut streets in Providence, is scheduled to ... a parcel of land the university purchased in 2012. , ...
(Date:5/4/2015)... “ LiveSchool ” was featured on ... a look at the latest and coolest applications on ... the host of AppWatch and technology expert, conducted the ... allows teachers to reward students with good behavior. , ... in the classroom. And the good people at ...
(Date:5/4/2015)... Healthcare Solutions is proud to be a sponsor at ... in Baltimore, MD from May 11 – 13, 2015. ... opportunity for clients to gather to network, attend educational ... to sponsoring the event, TROY Healthcare Solutions will be ... can stop by the TROY booth and see sample ...
(Date:5/4/2015)... NJ (PRWEB) May 04, 2015 The ... organization devoted exclusively to funding innovative lymphoma research and ... education programs, outreach initiatives and patient services – is ... the historic Mayfair Farms in West Orange, NJ on ... nearly $500,000 for innovative research programs through LRF. , ...
Breaking Medicine News(10 mins):Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2
... very famous Texan, the late Byron Nelson, is considered one ... his unprecedented, still-unbroken record of 11 consecutive tournament wins (18 ... of his short 15-year professional career ending in 1945, his ... excellence not only in sport, but in every aspect of ...
... of virus, genome should make finding a vaccine easier, CDC ... the genes that make up the new H1N1 swine flu ... a decade, researchers reported Friday. , Scientists at the U.S. ... genomes of more than 50 samples of the swine flu ...
... Honored by National Coalition for Homeless VeteransWASHINGTON, May 22 ... Unsung Hero Award at the 2009 Conference of the ... Iraq with the 10th Mountain Division. In 2006, ... sustained devastating injuries from an IED explosion that cost ...
... 22 Oklahoma Governor Brad Henry yesterday signed into ... reform legislation ever passed by the Oklahoma legislative and ... passage of the comprehensive reform by a vote of ... Oklahoma House of Representatives earlier that day by an ...
... Event raises $480,000 to make vital health and human ... More than 5,000 people converged on Angel Stadium ... annual rally against HIV/AIDS. Donations from OC AIDS ... and children are living with HIV/AIDS in our community. ...
... Texas, May 22 Animal welfare advocates throughout Texas ... position to oppose House Bill 3180, a bill to ... mills. "The TVMA,s decision to put the commercial ... animals suffering in puppy mills is appalling," said Cile ...
Cached Medicine News:Health News:The Byron Nelson: Championship Philosophy, Timeless Excellence 2Health News:The Byron Nelson: Championship Philosophy, Timeless Excellence 3Health News:Swine Flu Genes Went Undetected for Years: Report 2Health News:Swine Flu Genes Went Undetected for Years: Report 3Health News:Swine Flu Genes Went Undetected for Years: Report 4Health News:Swine Flu Genes Went Undetected for Years: Report 5Health News:Swine Flu Genes Went Undetected for Years: Report 6Health News:Swine Flu Genes Went Undetected for Years: Report 7Health News:Swine Flu Genes Went Undetected for Years: Report 8Health News:Swine Flu Genes Went Undetected for Years: Report 9Health News:Swine Flu Genes Went Undetected for Years: Report 10Health News:Swine Flu Genes Went Undetected for Years: Report 11Health News:Swine Flu Genes Went Undetected for Years: Report 12Health News:Oklahoma Passes Comprehensive Tort Reform: Governor Brad Henry Signs Reform Legislation 2Health News:Thousands Rally in Anaheim to Help People With HIV/AIDS 2Health News:Veterinary Group Opposes Bill to Clean Up Puppy Mill Industry 2
... physician preference card system as well as ... the supply management requirements of the surgical ... with a broad array of inventory management ... operating suite supply and charge capture workflow. ...
... Esteem™ External Vacuum Therapy System restores sexual ... men. Non-invasive and low cost vacuum therapy, ... desirable outcome", makes it the ideal therapy ... Therapy System causes penile rigidity that can ...
Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand....
... The D.O.R.C. Associate is an ... a Peristaltic and Venturi pump, allowing ... mode for Phaco or Vitrectomy procedures.,The ... is a microprocessor-controlled vacuum system that ...
Medicine Products: